These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17786164)

  • 1. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies.
    Mimeault M; Hauke R; Batra SK
    Clin Pharmacol Ther; 2008 May; 83(5):673-91. PubMed ID: 17786164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting multidrug resistance in cancer.
    Szakács G; Paterson JK; Ludwig JA; Booth-Genthe C; Gottesman MM
    Nat Rev Drug Discov; 2006 Mar; 5(3):219-34. PubMed ID: 16518375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
    Yu M; Ocana A; Tannock IF
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
    Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y
    Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy.
    Wu CP; Hsieh CH; Wu YS
    Mol Pharm; 2011 Dec; 8(6):1996-2011. PubMed ID: 21770407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of multidrug resistance in the age of targeted therapy.
    Türk D; Szakács G
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
    Cascorbi I; Haenisch S
    Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
    Joyce H; McCann A; Clynes M; Larkin A
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
    J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs.
    Lim MMK; Wee JWK; Soong JC; Chua D; Tan WR; Lizwan M; Li Y; Teo Z; Goh WWB; Zhu P; Tan NS
    Mol Cancer; 2018 Oct; 17(1):152. PubMed ID: 30342537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
    Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
    Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
    Gillet JP; Efferth T; Remacle J
    Biochim Biophys Acta; 2007 Jun; 1775(2):237-62. PubMed ID: 17572300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
    Lockhart AC; Tirona RG; Kim RB
    Mol Cancer Ther; 2003 Jul; 2(7):685-98. PubMed ID: 12883042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.
    Moitra K; Lou H; Dean M
    Clin Pharmacol Ther; 2011 Apr; 89(4):491-502. PubMed ID: 21368752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.